stock logo
ASTRAZEN
10,509.50
+314.50 (3.08%)

Astrazeneca Pharma India Ltd. (ASTRAZEN) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Astrazeneca Pharma India Ltd. (ASTRAZEN) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Today
Performance Of Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Today
Opening Price:10,029.00
Previous closing Price:10,195.00
Volume of Astrazeneca Pharma India Ltd. (ASTRAZEN) share:1,06,451
Value of Share:10,509.50
Fundamental of Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price
Market Capitalisation:26,312 Cr.
P/E Ratio:227.33
P/B Ratio:34.16
Sector P/E:44.33
EPS (TTM):46.30
Dividend Yield:0.30
14D - RSI:81.16
50 DMA:8,589.01
200 DMA:7,513.85

Note: The above data is mentioned as per the Astrazeneca Pharma India Ltd. (ASTRAZEN) share price today.

Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Today At NSE

    • Live Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price NSE India: ₹10,509.50
    • Previous Closing Price: ₹10,195.00
    • Open Price: ₹10,029.00
    • High: ₹10,691.00
    • Low: ₹9,961.00

Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Today At BSE

  • Live Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price BSE India: ₹10,524.65
  • Previous Closing Price: ₹10,178.55
  • Open Price: ₹10,140.00
  • High: ₹10,653.05
  • Low: ₹10,000.00

Historical Price Of Astrazeneca Pharma India Ltd. (ASTRAZEN) Share

The table below shows the variations in Astrazeneca Pharma India Ltd. (ASTRAZEN) share price from January 2018 to June 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 20181,136.451,160.001,270.301,102.602,02,344-2.03
February 20181,024.251,144.001,172.001,001.001,18,657-10.47
March 2018927.551,031.001,040.00919.9582,811-10.03
April 20181,044.35936.601,083.80930.0599,10511.5
May 20181,190.701,047.851,245.001,035.005,64,43413.63
June 20181,419.451,192.701,528.801,108.8529,23,72719.01
July 20181,530.651,419.451,574.951,370.106,27,5087.83
August 20181,891.251,539.001,960.001,528.9513,36,03122.89
September 20181,563.851,890.001,935.001,525.105,53,244-17.26
October 20181,714.901,565.051,785.501,490.103,53,4189.57
November 20181,392.701,714.001,748.851,365.153,41,024-18.75
December 20181,451.601,400.001,531.501,306.051,70,7203.69
January 20191,601.701,453.001,677.001,397.606,20,32610.23
February 20192,028.401,602.952,039.901,570.005,64,33426.54
March 20191,988.652,042.002,135.001,920.302,92,178-2.61
April 20192,358.002,004.002,395.001,927.004,31,02617.66
May 20191,969.202,350.002,397.701,950.004,15,473-16.2
June 20192,128.951,970.002,149.851,810.002,26,1038.07
July 20191,930.152,130.002,199.001,830.102,45,874-9.38
August 20191,880.651,930.151,992.101,632.555,33,425-2.56
September 20192,314.251,860.252,347.601,812.005,33,84424.41
October 20192,725.102,332.002,809.002,122.003,77,11616.86
November 20192,649.152,717.902,770.052,450.005,89,625-2.53
December 20192,616.602,649.152,931.852,590.006,46,654-1.23
January 20202,672.502,634.802,761.202,480.005,45,7361.43
February 20202,578.202,652.252,939.902,415.006,37,469-2.79
March 20202,403.852,585.002,730.001,885.006,91,051-7.01
April 20203,036.452,419.003,245.052,345.507,04,90625.53
May 20203,053.003,000.003,375.002,595.0014,75,4341.77
June 20203,547.703,097.003,670.003,017.0017,54,66414.55
July 20203,336.953,555.003,599.003,277.0013,02,288-6.13
August 20203,549.753,340.103,720.003,250.0012,39,4676.28
September 20204,303.753,549.754,970.003,503.8540,77,65821.24
October 20204,300.204,337.804,584.454,126.307,94,109-0.87
November 20204,538.904,250.004,612.954,180.0015,17,7246.8
December 20204,619.204,550.004,772.004,055.0520,15,5451.52
January 20213,625.454,639.004,910.003,540.0020,92,871-21.85
February 20213,436.253,650.354,050.003,110.2510,20,418-5.87
March 20213,009.303,472.003,542.903,005.009,23,374-13.33
April 20213,907.953,040.004,579.853,030.0557,31,57628.55
May 20213,777.953,910.003,960.003,750.006,91,174-3.38
June 20213,611.203,797.003,939.003,601.155,40,202-4.89
July 20213,369.503,611.003,675.003,360.053,03,641-6.69
August 20213,106.453,390.203,500.003,051.456,01,008-8.37
September 20213,089.603,110.003,250.003,075.003,54,418-0.66
October 20213,007.103,091.003,197.002,977.002,94,699-2.71
November 20213,137.153,025.803,349.002,958.206,05,5843.68
December 20213,098.253,170.003,232.002,972.003,34,049-2.26
January 20222,796.353,099.003,157.902,773.852,95,438-9.77
February 20222,609.552,817.302,869.902,529.702,19,009-7.37
March 20222,551.852,609.552,747.002,525.952,52,808-2.21
April 20222,749.752,552.002,926.002,552.002,24,6587.75
May 20223,007.552,713.003,025.002,445.704,86,73910.86
June 20222,705.202,906.002,997.902,654.901,14,492-6.91
July 20223,064.752,700.003,130.002,664.003,53,80713.51
August 20223,075.903,067.003,248.952,974.152,40,9770.29
September 20223,111.553,075.003,368.452,945.804,11,2691.19
October 20223,299.553,050.003,343.002,911.002,38,3368.18
November 20223,373.803,305.003,620.003,175.004,35,7972.08
December 20223,297.153,370.903,539.003,240.251,78,271-2.19
January 20233,361.053,253.003,599.003,253.001,00,7263.32
February 20233,344.653,361.053,480.003,186.0595,384-0.49
March 20233,252.803,312.003,466.953,103.601,19,303-1.79
April 20233,188.353,240.003,335.853,098.0066,986-1.59
May 20233,562.453,162.153,590.003,125.002,31,87212.66
June 20233,707.503,585.003,799.003,444.453,61,2723.42
July 20233,866.003,700.303,947.003,698.052,21,7574.48
November 20234,765.804,627.754,996.904,510.002,01,8262.98
December 20235,526.604,750.255,758.004,600.7011,87,45616.34
January 20246,616.605,500.006,872.005,500.007,56,89520.3
February 20245,516.556,616.607,220.955,228.455,17,051-16.63
March 20245,328.455,521.255,542.954,785.002,75,651-3.49
April 20245,335.305,256.305,595.855,039.004,62,8791.5
May 20246,179.255,206.006,697.004,800.156,55,00418.69
June 20246,250.756,379.006,999.005,468.052,06,030-2.01
July 20247,036.456,225.007,572.206,150.0013,01,25413.04
August 20246,586.657,108.057,250.056,464.653,11,133-7.34
September 20247,970.056,594.958,137.506,367.5534,87,07620.85
October 20247,624.907,735.058,139.006,955.0020,87,784-1.42
November 20246,590.007,600.007,777.006,220.004,42,620-13.29
December 20247,305.156,598.957,594.006,312.7510,86,10610.7
January 20257,235.107,225.007,444.000.004,17,6320.14
February 20256,698.657,235.107,726.106,670.003,39,396-7.41
March 20258,607.656,783.009,059.056,620.1012,41,39926.9
April 20258,681.008,602.009,211.007,201.155,99,9650.92
May 20257,972.008,610.008,700.007,800.003,13,386-7.41
June 202510,509.508,409.0010,691.008,400.5031,66,39124.98

Shareholding Pattern of Astrazeneca Pharma India Ltd. (ASTRAZEN) Shares In Stock Market

The below depicted shareholding pattern is as per the Astrazeneca Pharma India Ltd. (ASTRAZEN) Industries Ltd. Share Price Market of March 2025.

Promoters75.00%
Foreign Institutions2.89%
Retail and Others17.50%
Other Domestic Institutions0.16%
Mutual Funds4.45%
Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Background
Face Value2.00
ISININE203A01020
Market Lot1.00
InstrumentEQUITY
Should you invest in Astrazeneca Pharma India Ltd. (ASTRAZEN) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Astrazeneca Pharma India Ltd. (ASTRAZEN) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Astrazeneca Pharma India Ltd. (ASTRAZEN) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 26,312 Cr.
  • Astrazen FAQs

    Is Astrazeneca Pharma India Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Astrazeneca Pharma India Ltd. is in Buy zone for Short term and is in Buy zone for Long term.

    Should I buy Astrazeneca Pharma India Ltd. share now?

    arrow

    As per our verdict, Astrazeneca Pharma India Ltd. is in the Buy zone for Short term.

    Should I buy Astrazeneca Pharma India Ltd. shares for the long term?

    arrow

    As per our verdict, Astrazeneca Pharma India Ltd. is in Buy zone for Long term.

    What is Astrazeneca Pharma India Ltd. share price today?

    arrow

    The Astrazeneca Pharma India Ltd. share price today is 10509.5.

    How to buy Astrazeneca Pharma India Ltd. share?

    arrow

    You can buy Astrazeneca Pharma India Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Astrazeneca Pharma India Ltd.?

    arrow

    The share price of Astrazeneca Pharma India Ltd. is 10509.5, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Astrazeneca Pharma India Ltd.?

    arrow

    PE ratio of Astrazeneca Pharma India Ltd. is 227.33 and PB ratio of Astrazeneca Pharma India Ltd. is 34.16.

    How’s PE of Astrazeneca Pharma India Ltd. compared to its sector?

    arrow

    PE ratio of Astrazeneca Pharma India Ltd. is 227.33 whereas the sector PE ratio is 44.33.

    What is the market cap of Astrazeneca Pharma India Ltd.?

    arrow

    Astrazeneca Pharma India Ltd.’s market cap is 26312.

    What are today’s High and Low prices of Astrazeneca Pharma India Ltd. ?

    arrow

    Today’s High of Astrazeneca Pharma India Ltd. is 10691.
    Today’s Low of Astrazeneca Pharma India Ltd. is 9961.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    arrow down